Figure 1.

Timeline of the medication and computed tomography (CT) results before and during treatment. A pre-treatment enhanced CT scan was performed on April 11, 2022, showing multiple swollen lymph nodes in the right lower neck, bilateral supraclavicular areas, and left internal mammary area and mediastinum, and multiple low-density nodules in the liver. The first enhanced CT after starting treatment was on July 12, 2022, and showed that the multiple swollen lymph nodes in the right lower neck, bilateral supraclavicular areas, left internal mammary area, and mediastinum were smaller than before treatment, and multiple new ring-enhanced nodes appeared in the liver. The second enhanced CT scan after starting treatment was on August 30, 2022, and showed that the enlarged lymph nodes and liver nodules were smaller. The third enhanced CT scan after starting treatment was performed on March 15, 2023, and showed that the lymph nodes and liver lesions were stable. The fourth enhanced CT scan on June 20, 2023, showed that the lymph nodes were slightly smaller, while the liver lesions were roughly stable.